Procyon Corporation
PCYN
Price:
$0.229
Market Cap:
$1.86M
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound c...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-12-11
Stock Exchange
PNK
Ticker
PCYN
PE Ratio
[-5.72]
ROE
[-14.39%]
Current Ratio
[3.08]
Dividend Yield
[0%]
Enterprise Value
[1.85M]
Dividend History
The ROE as of December 2024 (TTM) for Procyon Corporation (PCYN) is -14.39%
According to Procyon Corporation’s latest financial reports and current stock price. The company's current ROE is -14.39%. This represents a change of 296.31% compared to the average of -3.63% of the last 4 quarters.
Procyon Corporation (PCYN) Historical ROE (quarterly & annually)
How has PCYN ROE performed in the past?
The mean historical ROE of Procyon Corporation over the last ten years is -1.20%. The current -14.39% ROE has changed 1.10% with respect to the historical average. Over the past ten years (40 quarters), PCYN's ROE was at its highest in in the June 2021 quarter at 15.33%. The ROE was at its lowest in in the December 2017 quarter at -19.61%.
Average
-1.20%
Median
-0.69%
Minimum
-14.91%
Maximum
23.53%
Procyon Corporation (PCYN) ROE by Quarter and Year
Discovering the peaks and valleys of Procyon Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 677.03%
Maximum Annual ROE = 23.53%
Minimum Annual Increase = -2426.01%
Minimum Annual ROE = -14.91%
| Year | ROE | Change |
|---|---|---|
| 2024 | -14.91% | 677.03% |
| 2023 | -1.92% | -75.59% |
| 2022 | -7.86% | -133.42% |
| 2021 | 23.53% | 355.96% |
| 2020 | 5.16% | 290.30% |
| 2019 | 1.32% | -110.50% |
| 2018 | -12.59% | -2426.01% |
| 2017 | 0.54% | -88.79% |
| 2016 | 4.83% | -147.66% |
| 2015 | -10.13% | -1118.18% |
Procyon Corporation (PCYN) Average ROE
How has PCYN ROE performed in the past?
The current ROE of Procyon Corporation (PCYN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.23%
5-year avg
0.80%
10-year avg
-1.20%
Procyon Corporation (PCYN) ROE vs. Peers
How is PCYN’s ROE compared to its peers?
Procyon Corporation’s ROE is less than Hypera S.A. (13.22%), greater than Sumitomo Pharma Co., Ltd. (-144.30%), less than Indivior PLC (4.22%), less than YourWay Cannabis Brands Inc. (0%), greater than Cumberland Pharmaceuticals Inc. (-40.17%), less than Genomma Lab Internacional, S.A.B. de C.V. (15.66%), less than City View Green Holdings Inc. (51.86%), less than West Island Brands Inc. (0%), greater than The BC Bud Corporation (-383.06%), greater than RAMM Pharma Corp. (-32.53%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), greater than Craftport Cannabis Corp. (-194.22%), greater than RavenQuest BioMed Inc. (-203.42%), less than Pure Harvest Corporate Group, Inc. (14.51%), less than Molecule Holdings Inc. (297.34%), less than Nippon Shinyaku Co., Ltd. (12.53%), less than Biome Grow Inc. (3.01%),
| Company | ROE | Market cap |
|---|---|---|
| 13.22% | $1.85B | |
| -144.30% | $1.64B | |
| 4.22% | $2.89B | |
| 0% | $17.82M | |
| -40.17% | $35.25M | |
| 15.66% | $1.27B | |
| 51.86% | $730.24K | |
| 0% | $4.77B | |
| -383.06% | $4.72M | |
| -32.53% | $15.16M | |
| -16.76% | $1.31K | |
| -194.22% | $6.28B | |
| -203.42% | $482.11K | |
| 14.51% | $478.27K | |
| 297.34% | $244.46K | |
| 12.53% | $1.79B | |
| 3.01% | $831.89K |
Build a custom stock screener for Procyon Corporation (PCYN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Procyon Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Procyon Corporation (PCYN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Procyon Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Procyon Corporation's ROE?
How is the ROE calculated for Procyon Corporation (PCYN)?
What is the highest ROE for Procyon Corporation (PCYN)?
What is the 3-year average ROE for Procyon Corporation (PCYN)?
What is the 5-year average ROE for Procyon Corporation (PCYN)?
How does the current ROE for Procyon Corporation (PCYN) compare to its historical average?